18 min listen
Episode 31: A Phase 2 Study of Nivolumab with the Addition of Ipilimumab Upon Progression in Renal Cancer
FromThe Uromigos
Episode 31: A Phase 2 Study of Nivolumab with the Addition of Ipilimumab Upon Progression in Renal Cancer
FromThe Uromigos
ratings:
Length:
25 minutes
Released:
May 29, 2020
Format:
Podcast episode
Description
Mike Atkins describes the results of this study which helps shed light on the role of ipilimumab and nivolumab in this disease.
Released:
May 29, 2020
Format:
Podcast episode
Titles in the series (100)
Episode 37: Regoratinib (FGFR inhibitor) and Atezolizumab in UC with Jonathan Rosenberg by The Uromigos